Jesus Alonso Gandara Mireles | Pharmacology, Toxicology and Pharmaceutical Science | Young Scientist Award

Published on by Academic Awards

Dr. Jesus Alonso Gandara Mireles | Pharmacology, Toxicology and Pharmaceutical Science | Young Scientist Award

Researcher,  National Polytechnic Institute,  Mexico.

Jesús Alonso Gándara Mireles is an exemplary candidate for the Research for Young Scientist Award, with extensive qualifications in biotechnology. He holds a Bachelor’s degree and multiple master’s degrees, culminating in a PhD focused on pharmacokinetics and pharmacogenetics in oncology. Currently completing a Postdoctoral Fellowship at the National Polytechnic Institute, Jesús conducts research aimed at optimizing chemotherapy for pediatric cancer patients. His experience includes prestigious internships at the University at Buffalo and the University of San Diego, enhancing his expertise. As a member of key professional organizations, he demonstrates a strong commitment to advancing personalized medicine and improving patient outcomes.

Publication Profile :

Scopus

Educational Background :

Jesús’s educational achievements are impressive and relevant to his research interests. He holds a Bachelor’s degree in Biotechnology with a biomedical focus, followed by a Master’s in Molecular and Cellular Biology, a Master’s in Human Genetics, and a Master’s in Clinical Pharmacokinetics. His PhD, centered on pharmacokinetics and pharmacogenetics in oncology, underscores his specialized knowledge in this vital area of research. This rigorous academic training has equipped him with the necessary skills to tackle complex scientific problems in the field of cancer treatment.

Professional Experiences :

Jesús Alonso Gándara Mireles has accumulated extensive professional experience in biotechnology and clinical research, particularly in the fields of pharmacogenetics and pharmacokinetics. Currently, he is completing a Postdoctoral Fellowship at the National Polytechnic Institute (IPN), focusing on the pharmacokinetics of oncology agents in pediatric patients. His previous internships include significant roles in Clinical Pharmacokinetics at the National Institute of Pediatrics and Pediatric Cancer Pharmacology at the University at Buffalo. He also engaged in research on Pediatric Cancer Genetics at the University of San Diego. His work aims to optimize treatment strategies and reduce chemotherapy-induced adverse effects in childhood cancer.

Research Contribution  :

Throughout his career, Jesús has gained valuable research experience through multiple internships. His exposure to pharmacokinetics and pharmacogenetics at prestigious institutions, including the University at Buffalo and the University of San Diego, highlights his capability to engage with leading experts and contribute to groundbreaking research. His current work focuses on optimizing chemotherapy for children by reducing adverse effects through personalized medicine, emphasizing his innovative approach to healthcare challenges.

Awards And Achievements :

Jesús Alonso Gándara Mireles has earned notable recogn ition throughout his academic and research career. As a member of the National System of Researchers (CONACYT) at Level 1, he has demonstrated his commitment to advancing scientific knowledge. His research contributions have been acknowledged through prestigious internships, including those at the National Institute of Pediatrics and the University at Buffalo. Additionally, Jesús is an active member of the International Society of Pediatric Oncology (SIOP) and the Latin American Society of Pharmacogenomics and Personalized Medicine (SOLFAGEM). These affiliations reflect his dedication to pediatric oncology and personalized medicine, underscoring his impactful contributions to the field.

Conclusion : 

Jesús Alonso Gándara Mireles is an outstanding candidate for the Research for Young Scientist Award. His impressive educational background, significant research experience, and active participation in professional networks make him a valuable contributor to the field of biotechnology and pediatric oncology. His work has the potential to greatly improve treatment outcomes for children with cancer, demonstrating his commitment to advancing scientific knowledge and enhancing patient care. Therefore, I strongly endorse his nomination for this esteemed award.

Publication Top Notes :

  • “Influence of Age, Gender and Body Mass Index on Intravenous Pharmacokinetics of Buprenorphine in Children Undergoing Orthopedic Surgery” (2024) – 🏥
  • “Population pharmacokinetics and pharmacodynamics of L-asparaginase and its impact on the development of pancreatitis and hypersensitivity reactions in children with leukemia under treatment” (2024) – 🧬
  • “Nutritional Status as a Risk Factor for Doxorubicin Cardiotoxicity in Mexican Children with Acute Lymphoblastic Leukemia” (2024) – 🍽️
  • “Impact of single-nucleotide variants and nutritional status on population pharmacokinetics of Doxorubicin, and its effect on cardiotoxicity in children with leukemia” (2023) – ⚗️ Cited by: 3
  • “Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia” (2021) – 🧬 Cited by: 8
  • “Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population” (2021) – 🔬 Cited by: 3

Lingyang Zhang | Toxicology | Best Researcher Award

Published on by Academic Awards

Dr. Lingyang Zhang | Toxicology | Best Researcher Award

Henan Academy of Sciences, China

Publication Profile

Scopus

 

Strengths for the Award

  1. Educational Background: Lingyang Zhang has a solid academic foundation, with a Bachelor’s and Master’s degree from Hunan University of Science and Technology and a Doctorate from Nankai University. This diverse educational experience reflects a strong commitment to advancing knowledge.
  2. Significant Publications: Zhang has contributed to high-impact research in notable journals such as Angewandte Chemie International Edition, ACS Applied Materials & Interfaces, and Analytica Chimica Acta. The focus on innovative areas like nanodrugs, protein couplings, and carbon dots highlights his expertise in cutting-edge research.
  3. Awards and Recognitions: The Bronze Award at the 2nd National Postdoctoral Innovation and Entrepreneurship Competition and selection for the Outstanding Postdoctoral Leadership Program in Henan Province demonstrate recognition of Zhang’s contributions and leadership in the field.
  4. Diverse Research Interests: His work spans various applications, including tumor therapy, protein interactions, and cellular imaging, showcasing a broad and impactful research portfolio.

Areas for Improvement

  1. Citation and Impact Metrics: Providing citation counts and impact factors for his publications would offer a clearer picture of the influence and reach of Zhang’s work. This quantitative data can be crucial in assessing the broader impact of his research.
  2. Broader Collaboration: Expanding collaborations with international research institutions could enhance the visibility and impact of his work. While his research is impressive, interdisciplinary and global collaborations often amplify a researcher’s influence.
  3. Research Diversity: While Zhang has a strong focus on specific areas, incorporating research into emerging or interdisciplinary fields could broaden his impact and showcase adaptability to new scientific challenges.

Conclusion

Lingyang Zhang is a highly qualified candidate for the “Research for Best Researcher Award.” His educational background, significant publications in reputable journals, and recognition through prestigious awards highlight his expertise and contributions to his field. By enhancing the visibility of his work through impact metrics and expanding research collaborations, Zhang could further strengthen his candidacy. Overall, his achievements and ongoing contributions make him a strong contender for the award.

 

 

Education

🎓 Zhang earned his Doctorate in Science from Nankai University (2016-2022) after completing his Master’s (2013-2016) and Bachelor’s (2013-2016) degrees at Hunan University of Science and Technology.

Experience

🔬 Zhang has been actively involved in cutting-edge research, focusing on the development of novel nanodrugs and advanced imaging techniques. His work includes efficient protein–protein couplings and ratiometric fluorescence imaging.

Research Focus

🔍 Zhang’s research centers on nanotechnology applications in tumor therapy, fluorescence imaging with carbon dots, and the development of innovative detection methods for biological markers.

Awards

🏅 Zhang has received the Bronze Award at the 2nd National Postdoctoral Innovation and Entrepreneurship Competition in China and was selected for the Outstanding Postdoctoral Leadership Program in Henan Province.

Publications

  1. Junling An, Zequn Zhang, Jinrui Zhang, Lingyang Zhang*, Gaofeng Liang*, Research progress in tumor therapy of carrier-free nanodrug, Biomedicine & Pharmacotherapy, 2024, 178, 117258.
  2. XunCheng Su*, LingYang Zhang, LiNa Zhao, BinBin Pan, BenGuang Chen, JiaLiang Chen, ChengLiang Zhai, and Bin Li. Efficient protein–protein couplings mediated by small molecules under mild conditions, Angewandte Chemie International Edition, 2022, 61, e202205597.
  3. Lingyang Zhang, Donghui Wang, Haowen Huang*, Lanfang Liu, Yuan Zhou, Xiaodong Xia, Keqin Deng, and Xuanyong Liu*. Preparation of gold−carbon dots and ratiometric fluorescence cellular imaging, ACS Applied Materials & Interfaces, 2016, 8, 6646−6655.
  4. Lingyang Zhang, Shenna Chen, Qian Zhao, Haowen Huang *, Carbon dots as a fluorescent probe for label-free detection of physiological potassium level in human serum and red blood cells, Analytica Chimica Acta, 2015, 880, 130–135.